Tocilizumab-Induced Acute Liver Injury in Adult Onset Still's Disease
{{output}}
Background. Tocilizumab, a monoclonal humanized anti-IL-6 receptor antibody, is used in treatment of refractory adult onset Still's disease (AOSD). Mild to moderate liver enzyme elevation is a well-known side effect, but severe liver injury has only been repor... ...
